Clerio Vision, Inc.

Perfecting the Sense of Sight

General Information
Company Name
Clerio Vision, Inc.
Founded Year
2014
Location (Offices)
United States +3
Founders / Decision Makers
Trevor McCaw - President and CCO Jay B. Baker - CFO Alex Zapesochny - CEO Mikael Totterman - Chairman of the Board & Chief Innovation Officer Alexandra Latypova - Co-Founder, Executive vice President and Director
Number of Employees
41
Industries
Biotechnology, Health Care, Medical Devices
Funding Stage
Series E
Social Media

Clerio Vision, Inc. - Company Profile

Clerio Vision, Inc. is a biotechnology startup with a mission to perfect the sense of sight. Founded in 2014 and headquartered in the United States, the company is focused on developing a groundbreaking product platform for the global ophthalmic market. Leveraging technology licensed from the University of Rochester, Clerio Vision is poised to disrupt the industry with a portfolio of next-generation products in contact lenses, myopia control, and cataract surgery.

The team behind Clerio Vision is a blend of serial entrepreneurs with multiple exits and industry veterans who have been at the forefront of pioneering new ophthalmic technology categories. This unique combination of experience and expertise positions the company for success in the highly competitive healthcare and biotechnology sectors. Currently, their products are in clinical development, signaling a phase of rapid innovation and growth.

The startup recently secured a significant $12.50M Venture Round investment on 03 February 2021 from Prox Ventures, highlighting the confidence of investors in the company's vision and potential. With a clear focus on revolutionizing the field of ophthalmology, Clerio Vision is a compelling investment opportunity for venture capitalists seeking to support cutting-edge biotechnology and healthcare innovations.

Taxonomy: ophthalmic technology, contact lenses, myopia control, cataract surgery, clinical development, ophthalmic industry, University of Rochester, serial entrepreneurs, startup, clinical trials, innovation, optical healthcare, vision enhancement

Funding Rounds & Investors of Clerio Vision, Inc. (9)

View All
Funding Stage Amount No. Investors Investors Date
Series E $12.50M 4
Norwest Venture Partners, investor in Clerio Vision, Inc.'s Series E round Safar Partners, investor in Clerio Vision, Inc.'s Series E round Proxima Ventures, investor in Clerio Vision, Inc.'s Series E round
Bridge Point Capital 		03 Feb 2021
Venture Round $8.26M 1
Norwest Venture Partners, investor in Clerio Vision, Inc.'s Venture Round round
22 Dec 2020
Series D $11.93M 8
Armory Square Ventures, investor in Clerio Vision, Inc.'s Series D round Norwest Venture Partners, investor in Clerio Vision, Inc.'s Series D round UpVentures Capital, investor in Clerio Vision, Inc.'s Series D round Safar Partners, investor in Clerio Vision, Inc.'s Series D round Topmark Partners, investor in Clerio Vision, Inc.'s Series D round
Mikael Totterman, Alex Zapesochny +1 		10 Jul 2019
Venture Round $2.95M 1 Stonehenge Growth Capital 06 Aug 2018
Grant $1.25M 1
National Science Foundation, investor in Clerio Vision, Inc.'s Grant round
13 Sep 2017

View All 9 Funding Rounds

Latest News of Clerio Vision, Inc.

View All

No recent news or press coverage available for Clerio Vision, Inc..

Similar Companies to Clerio Vision, Inc.

View All
Eyenovia, Inc. - Similar company to Clerio Vision, Inc.
Eyenovia, Inc. FDA Approved Drug-Device Ophthalmic Company
Ora - Similar company to Clerio Vision, Inc.
Ora Creating Vision Beyond What We See.
Advanced Ophthalmic Pharma - Similar company to Clerio Vision, Inc.
Advanced Ophthalmic Pharma Pioneering a new way in eye care with a preservative-free mist application for ophthalmic treatments.
Medennium Inc - Similar company to Clerio Vision, Inc.
Medennium Inc Think Better & See Different
Ocular Therapeutix, Inc. - Similar company to Clerio Vision, Inc.
Ocular Therapeutix, Inc.